Immudyne Appoints Karen Kingston, Former Brand St

Immudyne Appoints Karen Kingston, Former Brand Strategist for Johnson & Johnson, Pfizer, and Allergan, to Lead Global Marketing and Sales

NEW YORK, March 25, Mar 25, 2013 (GLOBE NEWSWIRE via COMTEX) -- Immudyne, Inc. (OTCQB:IMMD) announced today that Karen Kingston has been appointed as the company's Chief Marketing Officer to lead its global sales and marketing efforts.

Ms. Kingston has 15 years of experience successfully building brands and sales strategies within the men's health, eye care, skin care, immunology, and wellness industries. Most recently Ms. Kingston served as President & CEO of Varitage. Founded in 2007, Ms. Kingston leveraged her marketing expertise and technical knowledge to quickly secure Fortune 500 clients, including Johnson & Johnson, Medtronic, and Pfizer. Ms. Kingston also secured numerous medical device clients throughout the west coast, including OASIS Medical, Revision Optics, and Lumenis. Ms. Kingston has a stellar track record of transforming stagnant product portfolios into highly visible brands with accelerated revenue growth.

Prior to Varitage, Ms. Kingston spent more than 10 years working in sales and marketing for Pfizer, Allergan, and medical advertising agencies. She played a key role in marketing Viagra and was integral to shifting the brand focus to younger men and overall wellness.

"We are seeing increasing market demand for our Yeast Beta Glucan product line," said Mark McLaughlin, President & CEO of Immudyne. "Karen's know-how and proven ability to properly position and grow medical and wellness brands will be invaluable to us as we introduce new product lines from Immudyne's global portfolio."

As Chief Marketing Officer, Ms. Kingston will spearhead the launch of several new product lines based upon Immudyne's proprietary and patented Yeast Beta Glucan. She will also be responsible for the continued growth and management of Immudyne's sales and marketing team as well as the company's R&D of new product development initiatives.

"I believe there is tremendous opportunity to educate consumers on how critical the immune system is to overall health. Many adults are unaware that by taking simple actions to support their immune system, they can feel better, look better, and live healthier lives," said Ms. Kingston. "I am thrilled to have the opportunity to lead the marketing and sales efforts at Immudyne. Our products offer unique and meaningful benefits for both men and women and will help improve many, many lives."

About Immudyne

Immudyne is a health and wellness company with a portfolio of unique, patent-protected products for the medical, anti-aging, fitness, cosmeceutical, and wellness industries. Immudyne's extensively researched, patent-protected yeasted beta glucan, has an established history of providing clinically proven benefits to patients and consumers. Immudyne has offices located in Mt. Kisco, NY, Carlsbad, CA, and Florence, Kentucky.

Immudyne shares trade under the ticker symbol IMMD and the Company can be found on the web at www.immudyne.com (currently being transformed).

Cautionary language regarding Forward-Looking Statements Safe Harbor Act Disclaimer: Forward-looking statements in this release are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Certain statements in this press release may contain words such as "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "projects," "plans," "targets" and other similar language and are considered forward-looking statements. These statements are based on management's current expectations, estimates, and forecasts. These forward-looking statements are subject to important assumptions, risks and uncertainties, which are difficult to predict and therefore the actual results may be materially different from those discussed.

 CONTACT: Immudyne, Inc. 
 
         Mark McLaughlin 
 
         +1-914-714-8901 
 
         MarkMcL@immudyne.com 
 
 

http://www.globenewswire.com/newsroom/ti?nf=M...IjNjQ4MA==

 (C) Copyright 2013 GlobeNewswire, Inc. All rights reserved.